Evidence for a Radiation-responsive 'p53 Gateway' Contributing Significantly to the Radioresistance of Lepidopteran Insect Cells
Authors
Affiliations
Recently, we have demonstrated that microRNA-31 (miR-31) overexpression is inherent to radiation-induced cell death in the highly radioresistant Sf9 insect cells, and regulates pro-apoptotic Bax translocation to mitochondria. In the present study, we report that at sub-lethal radiation doses for Sf9 cells, miR-31 is significantly downregulated and is tightly regulated by an unusual mechanism involving p53. While ectopic overexpression of a well-conserved Sfp53 caused typical apoptosis, radiation-induced p53 accumulation observed selectively at sub-lethal doses failed to induce cell death. Further investigation of this paradoxical response revealed an intriguing phenomenon that sub-lethal radiation doses result in accumulation of a 'hyper-phosphorylated' Sfp53, which in turn binds to miR-31 genomic location and suppresses its expression to prevent cell death. Interestingly, priming cells with sub-lethal doses even prevented the apoptosis induced by lethal radiation or ectopic Sfp53 overexpression. On the other hand, silencing p53 increased radiation-induced cell death by inhibiting miR-31 downregulation. This study thus shows the existence of a unique radiation-responsive 'p53 gateway' preventing miR-31-mediated apoptosis in Sf9 cells. Since Sfp53 has a good functional homology with human p53, this study may have significant implications for effectively modulating the mammalian cell radioresistance.
Leng J, Su C, Carpenter D, Floyd W, Vaios E, Shenker R J Radiosurg SBRT. 2024; 9(2):91-99.
PMID: 39087065 PMC: 11288656.
On the Boundary of Exploratory Genomics and Translation in Sequential Glioblastoma.
Tompa M, Galik B, Urban P, Kajtar B, Kraboth Z, Gyenesei A Int J Mol Sci. 2024; 25(14).
PMID: 39062807 PMC: 11277311. DOI: 10.3390/ijms25147564.
Relationship between p53 status and the bioeffect of ionizing radiation.
Kong X, Yu D, Wang Z, Li S Oncol Lett. 2021; 22(3):661.
PMID: 34386083 PMC: 8299044. DOI: 10.3892/ol.2021.12922.
The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma.
Krayem M, Sabbah M, Najem A, Wouters A, Lardon F, Simon S Cancers (Basel). 2019; 11(8).
PMID: 31374895 PMC: 6721382. DOI: 10.3390/cancers11081093.